0%
Daily Market Update
20-Feb-20251 min readvipin kumar

NSE to introduce F&O contracts on Ireda and Tata Technologies from Feb 28- Daily Market Update 20th Feb 2025

Get a Smart Summary Instantly

Prompt copied

The National Stock Exchange on Wednesday said it will introduce futures and options contracts on Indian Renewable Energy Development Agency Ltd. and Tata Technologies Ltd. from Feb. 28. The move is subject to eligibility conditions, the exchange said in a circular, adding that it will announce details of market lot sizes, strike price schemes, and quantity freeze limits on Feb. 27.

Overview and Outlook

Global Stock Market Today

  • US equity markets settled on a flat note.
  • European equity markets ended lower in range 0.50% to 1.83%.
  • Asian equity markets are trading with negative bias.
  • GIFT Nifty is down by 50 points, Nifty futures likely to open around 22900 levels.

 

News highlights from across the globe

  • Asian equity markets are trading lower on Thursday, as tariff threats from the US President Donald Trump continued to weigh on risk appetite. Meanwhile, China kept its loan prime rates steady, focusing on financial stability.
  • The brent crude was trading 0.10% down at $72.18 a barrel.

 

Important news updates from the domestic front

  • Thomas Cook signed an agreement with SOTC and Korea Tourism Organisation for special projects.
  • Bharat Forge’s arm and AM General signed a letter of intent to supply artillery cannons to the US.
  • Waaree Energies received an order to supply solar modules for 362.5 MWp from an Engie India arm.
  • Mahindra & Mahindra: Mahindra Group entered a pact with Anduril Industries to develop autonomous maritime systems.
  • IRIS Business Services signed a memorandum of understanding with the Goa government to support the MSME ecosystem.
  • Cyient board appointed Sukamal Banerjee as the CEO for five years.
  • Rites signed an MoU with Central Water and Power Research Station for marine infra consultancy.
  • HFCL signed an agreement with BSNL as a project implementation agency under BharatNet Phase-III.
  • Orchid Pharma: US Food and Drug Administration ended inspections and issued seven minor observations on the Tamil Nadu facility.

 

Nifty Overview & Outlook

Benchmark Nifty index once again opened with a gap on the down side, smart recovery led by Banking and Finance pack helped it to recover the lost ground and finally it settled on a flat note at 22933 levels.

Broader markets outperformed the benchmark as Mid and Small cap index gained 1.19% & 2.36% respectively.

Majority of sectoral indices tracked at NSE settled in green. Amongst them, Metal, Media and Realty index were at the top of the tally, gained in range 1% to 1.67%. On the other hand, IT, Pharma and Healthcare index were the laggards, fell in range 0.5% to 1.35%.

Tecgnically, Nifty index is going through the short term congestion phase around its supports zone i.e. 22750-22800 spot levels. Cross and sustenance above 23000 spot levels might take it towards 23200-23250 spot levels in immediate near term. For any sustainable recovery it should close above 23250 spot levels.

 

Derivatives Overview & Outlook

Yesterday, Banknifty, Finnifty and Midcapnifty futures shed around 1%, 1.5% and 4% of open interest respectively as short covering, whereas no meaningful activities were seen seen in Nifty futures on price front.

Majority of sectoral indices settled on a positive note. Amongst them, Finance, Power, Realty and Technology stocks witnessed maximum addition of long positions along with some short covering in Chemicals stocks.

On option front, call writing along with some put writing was seen at multiple strikes and maximum positions are at 22500 PE and 23500 CE followed by 23100 CE.

 

Institutional Trading Activity

Yesterday, FIIs sold stocks worth Rs 1881 Cr in the cash segment, bought stocks futures worth Rs 725 Cr also bought index futures worth Rs 183 Cr. DIIs were net buyers in the cash segment to the tune of Rs 1958 Cr.

 

Nifty Futures, Banknifty Futures and Finnifty Key Levels

Nifty – Resistances 23050-23180; Supports 22880-22800

Banknifty – Resistances 49800-50000; Supports 49500-49350

Finnifty – Resistances 23550- 23620; Supports 23300-23200

 

F&O Security in Ban Today: MANAPPURAM

Disclosure

Globe Capital Market Limited (“GCML”) is a Stock Broker registered with BSE, NSE, MCX, NCDEX, and MSEI in all the major segments viz. Capital, F & O and CDS segments. GCML is also a Depository Participant and registered with both the Depositories viz. CDSL and NSDL. Further, GCML is a SEBI registered Portfolio Manager and Research Analyst. GCML includes subsidiaries, group and associate companies, promoters, directors, employees and affiliates.

AY Securities and Commodities Limited, Globe Derivatives and Securities Limited & Globe Fincap Limited are subsidiaries of GCML. AtoZ Finstock Private Limited, A to Z Consultants Private Limited, A to Z Venture Capital Limited, M. Agarwal Stock Brokers Private Limited, A M Share Brokers Private Limited, Shri Adinath Advertising Company Pvt. Ltd., Orient Landbase Private Limited, Bolt Synthetic Private Limited, Price ponder Private Limited, Lakshya Impex Private Limited and Launchpad Fintech Private Limited are associates of GCML.

This report has been prepared by GCML and published in accordance with the provisions of Regulation 19 of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014, for use by the recipient as information only and is not for general circulation or public distribution. This report is not to be altered, transmitted, reproduced, copied, redistributed, uploaded, published or made available to others, in any form, in whole or in part, for any purpose without prior written permission from GCML. The projections and the forecasts described in this report are based on estimates and assumptions and are inherently subject to significant uncertainties and contingencies. Projections and forecasts are necessarily speculative in nature, and it can be expected that one or more of the estimates on which the projections are forecasts were based may not materialize or may vary significantly from actual results and such variations will likely increase over the period of time. This report should not be construed as an offer to sell or the solicitation of an offer to buy, purchase or subscribe to any securities, and neither this report nor anything contained therein shall form the basis of or be relied upon in connection with any contract or commitment whatsoever. It does not constitute a personal recommendation or take into account the particular investment objective, financial situation or needs of any individual in particular. The research analysts of GCML have adhered to the code of conduct under Regulation 24 (2) of the Securities and Exchange Board of India (Research Analysts) Regulations, 2014. The recipients of this report must make their own investment decisions, based on their own investment objectives, financial situation or needs and other factors. The recipients should consider and independently evaluate whether it is suitable for its/ his/ her/their particular circumstances and if necessary, seek professional / financial advice as there is substantial risk of loss. GCML does not take any responsibility thereof.

Any such recipient shall be responsible for conducting his/her/its/their own investigation and analysis of the information contained or referred to in this report and of evaluating the merits and risks involved in securities forming the subject matter of this report. The price and value of the investment referred to in this report and income from them may go up as well as down, and investors may realize profit/loss on their investments. Past performance is not a guide for future performance. Actual results may differ materially from those set forth in the projection.

This report has been prepared by GCML based on the information available in the public domain and other public sources believed to be reliable. Though utmost care has been taken to ensure its accuracy and completeness, no representation or warranty, express or implied is made by GCML that such information is accurate or complete and/or is independently verified. The contents of this report represent the assumptions and projections of GCML and GCML does not guarantee the accuracy or reliability of any projection, assurances or advice made herein. Nothing in this report constitutes investment, legal, accounting and/or tax advice or a representation that any investment or strategy is suitable or appropriate to recipients’ specific circumstances.

Since GCML or its associates are engaged in various financial activities, they might have financial interest or beneficial ownership in various companies including subject company/companies mentioned in the report. GCML or its associates have not received any compensation for investment banking or merchant banking from the subject company in the past 12 months.  GCML or its associates might have received any compensation including brokerage services and for products or services other than investment banking or merchant banking from the subject company in the past 12 months. It is confirmed that GCML or research analyst or its associates have not managed or co-managed public offering of securities for the subject company in the past 12 months.

Research analyst or GCML or its relatives’/associates’ have no material conflict of interest at the time of publication of this report. Neither research analyst nor GCML are engaged in market making activity for the subject company. It is confirmed that research analysts do not serve as an officer, director or employee of the subject company. It is also confirmed that research analyst have not received any compensation from the subject company in the past 12 months. GCML or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.

No material disciplinary action has been taken on GCML by any regulatory authority impacting Equity Research Analysis activities.

The views contained in this document are those of the analyst, and the company may or may not subscribe to all the views expressed within. This information is subject to change, as per applicable law, without any prior notice. GCML reserves the right to make modifications and alternations to this statement, as may be required, from time to time.

Research analyst or GCML or its relatives’/associates’ do not have actual/beneficial ownership of 1% or more in securities of the subject company, at the end of the month immediately preceding the date of publication of the document.

Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.